[1] ZHAO L W, LI C, ZHANG R L, et al. B7-H1 and B7-H4 expression in colorectal carcinoma:correlation with tumor FOXP3(+) regulatory T-cell infiltration[J]. Acta Histochem, 2014, 116(7):1163-1168.; [2] ENKHBAT T, NISHI M, TAKASU C, et al. Programmed cell death ligand 1 expression is an independent prognostic factor in colorectal cancer[J]. Anticancer Res, 2018, 38(6):3367-3373.; [3] 朱明, 孙静, 王辉, 等. 负性共刺激分子B7-H1和B7-H4在结直肠癌中的表达及其临床意义[J]. 中国肿瘤生物治疗杂志, 2011, 18(5):528-532.; [4] 李晓凤, 巴彩霞, 袁海清, 等. B7-H1和Bcl-2在人结直肠癌中表达及其临床意义[J]. 肿瘤, 2012, 32(7):555-558.; [5] YUAN F, SUN R F, LI L J, et al. A functional variant rs353292 in the flanking region of miR-143/145 contributes to the risk of colorectal cancer[J]. Sci Rep, 2016, 6:30195.; [6] HU Z B, CHEN J P, TIAN T, et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival[J]. J Clin Invest, 2008, 118(7):2600-2608.; [7] WANG W P, SUN J, LI F, et al. A frequent somatic mutation in CD2743'-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding[J]. Hum Mutat, 2012, 33(3):480-484.; [8] WANG W P, LI F, MAO Y, et al. A miR-570 binding site polymorphism in the B7-H1 gene is associated with the risk of gastric adenocarcinoma[J]. Hum Genet, 2013, 132(6):641-648.; [9] 程仕光, 李清, 彭宇, 等. PD-L1基因多态性与肝癌易感性以及预后之间的关系[J]. 第三军医大学学报, 2017, 39(5):487-492.; [10] 王兰, 张永东, 郭红云, 等. XRCC3基因多态性与西北地区妇女乳腺癌的关联性研究[J]. 癌变·畸变·突变, 2019, 31(5):392-396, 400.; [11] 应伟, 王兴远, 江波, 等. miR-146a多态性与非小细胞肺癌易感性的研究[J]. 癌变·畸变·突变, 2019, 31(3):222-226.; [12] TAO L H, ZHOU X R, LI F C, et al. A polymorphism in the promoter region of PD-L1 serves as a binding-site for SP1 and is associated with PD-L1 overexpression and increased occurrence of gastric cancer[J]. Cancer Immunol Immunother, 2017, 66(3):309-318.; [13] XIE Q G, CHEN Z L, XIA L, et al. Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population[J]. Gene, 2018, 674:188-194.; [14] `TAN D, SHENG L, YI Q H. Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer[J]. Cancer Biomark, 2018, 21(2):287-297.; [15] YEO M K, CHOI S Y, SEONG I O, et al. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma[J]. Hum Pathol, 2017, 68:103-111.; [16] DU W W, ZHU J J, CHEN Y B, et al. Variant SNPs at the microRNA complementary site in the B7-H13'-untranslated region increase the risk of non-small cell lung cancer[J]. Mol Med Rep, 2017, 16(3):2682-2690.; [17] NOMIZO T, OZASA H, TSUJI T, et al. Clinical impact of single nucleotide polymorphism in PD-L1 on response to nivolumab for advanced non-small-cell lung cancer patients[J]. Sci Rep, 2017, 7:45124.; [18] ZHOU R M, LI Y, LIU J H, et al. Programmed death-1 ligand-1 gene rs2890658 polymorphism associated with the risk of esophageal squamous cell carcinoma in smokers[J]. Cancer Biomark, 2017, 21(1):65-71.; [19] KOCARNIK J D, HUTTER C M, SLATTERY M L, et al. Characterization of 9p24 risk locus and colorectal adenoma and cancer:gene-environment interaction and meta-analysis[J]. Cancer Epidemiol Biomarkers Prev, 2010, 19(12):3131-3139. |